Institutional investors hold a majority ownership of BCR through the 81.55% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2017, these large investors purchased a net $105.9 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITIGROUP GLOBAL MARKETS, INC. (... Bought 526.5 Thousand shares of C R Bard Inc
CITADEL ADVISORS LLC Bought 504.2 Thousand shares of C R Bard Inc
NATIXIS ASSET MANAGEMENT SA Bought 351.2 Thousand shares of C R Bard Inc